[{"id":"43035839-3bf9-43e5-bbd5-afd4d6d1337c","acronym":"","url":"https://clinicaltrials.gov/study/NCT02981940","created_at":"2021-01-18T14:40:08.944Z","updated_at":"2024-07-02T16:35:41.812Z","phase":"Phase 2","brief_title":"A Study of Abemaciclib in Recurrent Glioblastoma","source_id_and_acronym":"NCT02981940","lead_sponsor":"Dana-Farber Cancer Institute","biomarkers":" CDKN2A • RB1 • CDK4 • CDKN2B • CDK6","pipe":" | ","alterations":" CDKN2A deletion • CDK4 amplification • IDH wild-type • RB1 wild-type","tags":["CDKN2A • RB1 • CDK4 • CDKN2B • CDK6"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CDKN2A deletion • CDK4 amplification • IDH wild-type • RB1 wild-type"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Verzenio (abemaciclib)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 45","initiation":"Initiation: 02/09/2017","start_date":" 02/09/2017","primary_txt":" Primary completion: 06/01/2024","primary_completion_date":" 06/01/2024","study_txt":" Completion: 06/01/2025","study_completion_date":" 06/01/2025","last_update_posted":"2023-07-27"},{"id":"e0e1ee61-5bf4-4f29-bfd2-dc13f92d061d","acronym":"","url":"https://clinicaltrials.gov/study/NCT04118036","created_at":"2021-01-18T20:07:39.336Z","updated_at":"2024-07-02T16:36:19.524Z","phase":"Phase 2","brief_title":"Abemaciclib + Pembrolizumab In Glioblastoma","source_id_and_acronym":"NCT04118036","lead_sponsor":"Dana-Farber Cancer Institute","biomarkers":" CDKN2A • RB1 • CDKN2B • CASP3","pipe":" | ","alterations":" CDKN2A deletion • RB1 wild-type","tags":["CDKN2A • RB1 • CDKN2B • CASP3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CDKN2A deletion • RB1 wild-type"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Keytruda (pembrolizumab) • Verzenio (abemaciclib)"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 12/01/2021","start_date":" 12/01/2021","primary_txt":" Primary completion: 12/01/2023","primary_completion_date":" 12/01/2023","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2021-12-14"}]